{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:12:11Z","timestamp":1784121131848,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4011759"],"award-info":[{"award-number":["4011759"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.taap.2026.117904","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:18:22Z","timestamp":1781021902000},"page":"117904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Brefeldin A induces apoptosis in cisplatin-resistant ovarian cancer cells independent of ABCC2-mediated drug efflux"],"prefix":"10.1016","volume":"514","author":[{"given":"Seyedeh Mona","family":"Haghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tavakkoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Iranshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Kalalinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mosaffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.taap.2026.117904_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2021.101728","article-title":"Brefeldin a: a newly identified cell death inducer selectively targets radio-resistant colorectal cancer cells by direct interacting with caspase-3","volume":"34","author":"Bei","year":"2022","journal-title":"J King Saud Univ Sci."},{"key":"10.1016\/j.taap.2026.117904_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-4274(02)00497-6","article-title":"The role of multidrug transporters in drug availability, metabolism and toxicity","volume":"140-141","author":"Bod\u00f3","year":"2003","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.taap.2026.117904_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"24","key":"10.1016\/j.taap.2026.117904_bb0020","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.taap.2026.117904_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/15743624113086660005","article-title":"Brefeldin a inhibits cancer stem cell properties in human lung cancer cells","volume":"8","author":"Chao Neng","year":"2013","journal-title":"Curr. Signal Transduct. Ther."},{"key":"10.1016\/j.taap.2026.117904_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1475-2867-5-30","article-title":"ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal","volume":"5","author":"Choi","year":"2005","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.taap.2026.117904_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.leukres.2003.10.015","article-title":"Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines","volume":"28","author":"Dogan","year":"2004","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.taap.2026.117904_bb0040","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/bjc.2011.84","article-title":"Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis","volume":"104","author":"Duiker","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.taap.2026.117904_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2026.117904_bb0050","article-title":"Measuring cell cycle progression kinetics with metabolic labeling and flow cytometry","volume":"63","author":"Fleisig","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.taap.2026.117904_bb0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41571-025-01059-1","article-title":"Understanding and overcoming multidrug resistance in cancer","volume":"22","author":"Ge","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1097-458X(200004)38:4<274::AID-MRC630>3.0.CO;2-M","article-title":"NMR structure determination of brefeldin a, a 13-membered ring fungal metabolite","volume":"38","author":"Glaser","year":"2000","journal-title":"Magn. Reson. Chem."},{"issue":"10","key":"10.1016\/j.taap.2026.117904_bb0065","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3390\/molecules22101484","article-title":"In vitro assessment of the effect of antiepileptic drugs on expression and function of ABC transporters and their interactions with ABCC2","volume":"22","author":"Grewal","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.taap.2026.117904_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.290","article-title":"PROTACs: a novel strategy for cancer drug discovery and development","volume":"4","author":"Han","year":"2023","journal-title":"MedComm"},{"issue":"Pt 3","key":"10.1016\/j.taap.2026.117904_bb0075","article-title":"Chemical proteomics accelerates the target discovery of natural products","volume":"230","author":"He","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.taap.2026.117904_bb0080","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1080\/14786419.2016.1169414","article-title":"New analogues of brefeldin a from sediment-derived fungus Penicillium sp. DT-F29","volume":"30","author":"Hu","year":"2016","journal-title":"Nat. Prod. Res."},{"issue":"11","key":"10.1016\/j.taap.2026.117904_bb0085","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.bmcl.2017.04.047","article-title":"Brefeldin a enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D cultures","volume":"27","author":"Huang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0090","first-page":"176","article-title":"Apoptosis induction with combined use of cisplatin and fisetin in cisplatin-resistant ovarian cancer cells (A2780)","volume":"13","author":"Jafarzadeh","year":"2021","journal-title":"Avicenna J Med Biotechnol."},{"issue":"30","key":"10.1016\/j.taap.2026.117904_bb0095","doi-asserted-by":"crossref","first-page":"26461","DOI":"10.1074\/jbc.M111.232728","article-title":"Drug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis induction","volume":"286","author":"Jiang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.taap.2026.117904_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914574","article-title":"Oxidative damage as a fundament of systemic toxicities induced by cisplatin-the crucial limitation or potential therapeutic target?","volume":"24","author":"Katani\u0107 Stankovi\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ymthe.2004.11.016","article-title":"Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1\/P-gp, MRP2, and BCRP","volume":"11","author":"Kowalski","year":"2005","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2026.117904_bb0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cells10020376","article-title":"Authentic and ectopically expressed MRGPRX2 elicit similar mechanisms to stimulate degranulation of mast cells","volume":"10","author":"Lazki-Hagenbach","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.taap.2026.117904_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bcpt.12107","article-title":"Brefeldin a induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits focal adhesion kinase-mediated cell invasion","volume":"113","author":"Lee","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2026.117904_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.livres.2025.01.004","article-title":"Combination of brefeldin a and tunicamycin induces apoptosis in HepG2 cells through the endoplasmic reticulum stress-activated PERK-eIF2\u03b1-ATF4-CHOP signaling pathway","volume":"9","author":"Li","year":"2025","journal-title":"Liver Res."},{"issue":"6","key":"10.1016\/j.taap.2026.117904_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.20892\/j.issn.2095-3941.2025.0145","article-title":"Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches","volume":"22","author":"Li","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.taap.2026.117904_bb0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12885-024-12264-z","article-title":"Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195401","article-title":"Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs actinomycin D and vinblastine through ERK and AKT signaling","volume":"13","author":"Luchsinger","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.taap.2026.117904_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.rhisph.2020.100300","article-title":"Phytotoxins from Dactylonectria torresensis involved in replant disease of fruit trees","volume":"17","author":"Manici","year":"2021","journal-title":"Rhizosphere"},{"key":"10.1016\/j.taap.2026.117904_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.rhisph.2024.100906","article-title":"Phytotoxicity of Dactylonectria spp. exudates on kiwifruit vine and profile of secondary metabolites for understanding their relationship with the host plant","volume":"30","author":"Manici","year":"2024","journal-title":"Rhizosphere"},{"issue":"8","key":"10.1016\/j.taap.2026.117904_bb0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","article-title":"Artificial intelligence for proteomics and biomarker discovery","volume":"12","author":"Mann","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.taap.2026.117904_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177965","article-title":"Reactivating apoptotic pathways in cancer: a review of novel therapeutic approaches","volume":"1003","author":"Mantri","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2026.117904_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbrc.2006.07.022","article-title":"RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells","volume":"348","author":"Materna","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl. 3","key":"10.1016\/j.taap.2026.117904_bb0165","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","article-title":"Primary ovarian cancer chemotherapy: current standards of care","volume":"89","author":"McGuire","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.taap.2026.117904_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.taap.2026.117904_bb0175","first-page":"815","article-title":"Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein 2 (MRP2) inhibitors","volume":"24","author":"Mosaffa","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"9375","key":"10.1016\/j.taap.2026.117904_bb0180","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.taap.2026.117904_bb0185","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0190","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"20","key":"10.1016\/j.taap.2026.117904_bb0195","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.2009.25.7519","article-title":"Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse","volume":"28","author":"Pujade-Lauraine","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.taap.2026.117904_bb0200","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17568919.2025.2498875","article-title":"Key advances and application prospects of PROTAC technologies in the next 5 years","volume":"17","author":"Qin","year":"2025","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.taap.2026.117904_bb0205","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/acs.jnatprod.6b01085","article-title":"Fungal identification using molecular tools: a primer for the natural products research community","volume":"80","author":"Raja","year":"2017","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0210","first-page":"723","article-title":"Enhanced GM3 expression, associated with decreased invasiveness, is induced by Brefeldin a in bladder cancer cells","volume":"19","author":"Satoh","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2026.117904_bb0215","article-title":"Phaeosphaeride A isolated from an endophytic Paraphoma sp. alleviates ABCG2-mediated resistance to mitoxantrone in breast cancer cells","author":"Tavakkoli","year":"2026","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.taap.2026.117904_bb0220","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00006676-200310000-00004","article-title":"Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of Brefeldin a on the resistant cell line","volume":"27","author":"Togawa","year":"2003","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0225","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.taap.2026.117904_bb0230","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.3390\/molecules180910242","article-title":"Brefeldin a effectively inhibits cancer stem cell-like properties and MMP-9 activity in human colorectal cancer Colo 205 cells","volume":"18","author":"Tseng","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2026.117904_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172883","article-title":"Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells","volume":"868","author":"Valinezhad Sani","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2026.117904_bb0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.34172\/PS.2022.44","article-title":"Fucoxanthin inhibits the proliferation of ABCC2-over expressing cisplatin-resistance ovarian cancer cells via inducing apoptosis","volume":"29","author":"Valinezhad Sani","year":"2023","journal-title":"Pharm Sci."},{"issue":"5","key":"10.1016\/j.taap.2026.117904_bb0245","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/bjc.1996.103","article-title":"Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1\/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion","volume":"73","author":"Verovski","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2026.117904_bb0250","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.simyco.2014.09.001","article-title":"Identification and nomenclature of the genus Penicillium","volume":"78","author":"Visagie","year":"2014","journal-title":"Stud. Mycol."},{"issue":"2","key":"10.1016\/j.taap.2026.117904_bb0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.critrevonc.2015.05.012","article-title":"The role of ABC transporters in ovarian cancer progression and chemoresistance","volume":"96","author":"Ween","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.taap.2026.117904_bb0260","series-title":"PCR Protocols: A Guide to Methods and Applications","first-page":"315","article-title":"Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics","author":"White","year":"1990"},{"issue":"5","key":"10.1016\/j.taap.2026.117904_bb0265","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3892\/or.2016.4656","article-title":"Effect of brefeldin a and castanospermine on resistant cell lines as supplements in anticancer therapy","volume":"35","author":"Wojtowicz","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2026.117904_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116725","article-title":"PROTAC technology: from drug development to probe technology for target deconvolution","volume":"276","author":"Yan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0275","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","article-title":"Multidrug resistance proteins (MRPs) and cancer therapy","volume":"17","author":"Zhang","year":"2015","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.taap.2026.117904_bb0280","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1096\/fj.201801983R","article-title":"Brefeldin a inhibits colorectal cancer growth by triggering Bip\/Akt-regulated autophagy","volume":"33","author":"Zhou","year":"2019","journal-title":"FASEB J."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:02:42Z","timestamp":1784120562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"alternative-id":["S0041008X26002000"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117904","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brefeldin A induces apoptosis in cisplatin-resistant ovarian cancer cells independent of ABCC2-mediated drug efflux","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117904"}}